Anti-Mullerian hormone and polycystic ovary syndrome

被引：11
|
作者：
Lebkowska, Agnieszka [1 ]
Kowalska, Irina [1 ]
机构：
[1] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Sklodowskiej 24a,15-276, Bialystok, Poland
来源：
ENDOKRYNOLOGIA POLSKA | 2017年 / 68卷 / 01期
关键词：
AMH; PCOS; polycystic ovarian morphology; insulin resistance; assisted reproductive technology; ENZYME-LINKED-IMMUNOSORBENT; SMALL ANTRAL FOLLICLES; HUMAN GRANULOSA-CELLS; ANTIMULLERIAN HORMONE; MLLERIAN HORMONE; INHIBIN-B; PATIENT CHARACTERISTICS; INSULIN-RESISTANCE; FOLLICULAR-FLUID; SYNDROME PCOS;
D O I：
10.5603/EP.a2016.0065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anti-Mullerian hormone (AMH) is a glycoprotein, a member of the transforming growth factor beta family, reflecting the number of ovarian antral follicles. Polycystic ovary syndrome (PCOS) is a common endocrinopathy predisposing to infertility, and metabolic and cardiovascular complications. In our review, we discuss the role of AMH in PCOS pathophysiology and its clinical applications according to the published studies. Improvement of AMH assay validity will allow the clinical utility of this valuable biomarker to be widened.
引用
收藏
页码：74 / 78
页数：5
相关论文
共 50 条
  • [1] Anti-Mullerian hormone and polycystic ovary syndrome
    Catteau-Jonard, S.
    Dewailly, D.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (09): : 514 - 517
  • [2] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Bhattacharya, Koushik
    Saha, Ishita
    Sen, Debanjana
    Bose, Chaitali
    Chaudhuri, Gargi Ray
    Dutta, Sulagna
    Sengupta, Pallav
    Bhattacharya, Soumita
    Barman, Sharit Shekhar
    Syamal, Alak Kumar
    [J]. MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2022, 27 (01)
  • [3] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Koushik Bhattacharya
    Ishita Saha
    Debanjana Sen
    Chaitali Bose
    Gargi Ray Chaudhuri
    Sulagna Dutta
    Pallav Sengupta
    Soumita Bhattacharya
    Sharit Shekhar Barman
    Alak Kumar Syamal
    [J]. Middle East Fertility Society Journal, 27
  • [4] Anti-Mullerian hormone in patients with polycystic ovary syndrome
    Chebotnikova, T.
    Ilyin, A.
    Melnichenko, G.
    Chernukha, G.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2012, 34 (01): : 140 - 140
  • [5] Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome
    Fonseca, Helena Proni
    Brondi, Renata Suzuki
    Piovesan, Fernanda Xavier
    Miklos, Thomas Gabriel
    Aldrighi, Jose Mendes
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (09) : 667 - 670
  • [6] Role of Anti-Mullerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
    Dewailly, Didier
    Barbotin, Anne-Laure
    Dumont, Agathe
    Catteau-Jonard, Sophie
    Robin, Geoffroy
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [7] Pathogenic Anti-Mullerian Hormone Variants in Polycystic Ovary Syndrome
    Gorsic, Lidija K.
    Kosova, Gulum
    Werstein, Brian
    Sisk, Ryan
    Legro, Richard S.
    Hayes, M. Geoffrey
    Teixeira, Jose M.
    Dunaif, Andrea
    Urbanek, Margrit
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (08): : 2862 - 2872
  • [8] Anti-Mullerian hormone reflects the severity of polycystic ovary syndrome
    Jacob, S. L.
    Field, H. P.
    Calder, N.
    Picton, H. M.
    Balen, A. H.
    Barth, J. H.
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 86 (03) : 395 - 400
  • [9] Anti-Mullerian hormone measurement for the diagnosis of polycystic ovary syndrome
    Sathyapalan, Thozhukat
    Al-Qaissi, Ahmed
    Kilpatrick, Eric S.
    Dargham, Soha R.
    Atkin, Stephen L.
    [J]. CLINICAL ENDOCRINOLOGY, 2018, 88 (02) : 258 - 262
  • [10] Is the anti-mullerian hormone involved in luteinizing hormone dysregulation of the polycystic ovary syndrome?
    Jonard, S.
    Reyss, A. C.
    Decanter, C.
    Pigny, P.
    Dewailly, D.
    [J]. HUMAN REPRODUCTION, 2007, 22 : I105 - I105
12345